江西霞光企业集团有限公司新建年产150吨三磷腺苷酸(ATP)

lwdfjw

项目单位：江西霞光企业集团有限公司

　　项目地址：江西省上饶工业园区

　　项目内容：新建年产150吨三磷腺苷酸(ATP)产业化生产线。市场分析：ATP是一种重要的核苷酸类药物核生化试剂，属国家生物医药重点发展项目，目前国内需求量200多吨，而生产量只有10吨左右。在临床上对进行性肌肉萎缩、中风后遗症、心肌炎、冠状动脉硬化、肝炎等病症具有良好的治疗作用。该产品生产成本900元/公斤，市场销售价1800元/公斤，投资回报率高，预期经济效益显著。

　　预计投资及预期经济效益：总投资2875万美元。可实现年销售收入5375万美元，投资利润率45.8%，投资回报率60.94%。

　　合作方式：合作、合资

　　联系人：桑高良

　　联系电话：0793-8492081

　　PRODUCTION LINE PROJECT OF ADENOSINETRIPHOSPHATASE (ATP)

　　PROJECT UNIT： Jiangxi Xiaguang Enterprise Group Company, Ltd.

　　LOCATION： The Industrial Park, Shangrao City, Jiangxo Province

　　PROJECT CONTENTS： To build a production line and the annual capacity of 150 tons of adenosinetriphosphatase (ATP).

　　MARKET FORECAST： ATP is an important reagent for nucleotide medicine and is a key project to be developed. At the present the domestic demand for it is about 200 tons, but the production capacity is only about 10 tons. The medicine is good for treating the progressive muscular dystrophy, coronary sclerosis, hepatitis, myocarditis, side effect of stroke. The production cost of the medicine is RMB 900 yuan each kg, but the market price is RMB 1,800 yuan each kg. The return on the investment is high.

　　ESTIMATED INVESTMENT AND ECONOMIC BENEFIT： The total investment would be USD 28.75 million, the annual sales income would be USD 53.75 million, the profit to investment ratio would be 45.8% and the rate of return on investment would be 60.94%.

　　FORM OF COOPERATION： Cooperation or joint venture.

　　CONTACT PERSON： Sang Gaoliang

　　TEL.： 0793-8492081